Laboratory medicine in the new healthcare environment

Clinical Chemistry and Laboratory Medicine

Volumn 54, Issue 4, 2016, Pages 523-533

  Ferraro, Simona ^a   Braga, Federica ^a   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

analytical validity; laboratory medicine; laboratory clinic interface; patient outcomes

Indexed keywords

TROPONIN;

ANALYTICAL PARAMETERS; CLINICAL EVALUATION; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; INTERPERSONAL COMMUNICATION; LABORATORY; LABORATORY MEDICINE; LABORATORY PERSONNEL; LABORATORY TEST; LEADERSHIP; MEDICAL RESEARCH; MEDICINE; OCCUPATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PRODUCTIVITY; REVIEW; VALIDITY; MEDICAL TECHNOLOGY;

DELIVERY OF HEALTH CARE; HUMANS; MEDICAL LABORATORY SCIENCE;

EID: 84961843684     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0803     Document Type: Review

References (91)

1. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001.
2. Department of Health - Diagnostic Services in 2020 and beyond: Visioning for the future v1.9 December 2012. Available at www.oxford.dec.nihr.ac.uk (Accessed July 2015).
3. Wolcott J, Schwartz A, Goodman C. Laboratory medicine: a national status report. May 2008. Available at www.cdc.gov/.../2007%20status%20report%20laboratory-medicine. Accessed July 2015.
4. Hallworth MJ. The '70% claim': what is the evidence base? Ann Clin Biochem 2011;48:487-8.
5. Scott MG, Rifai N, Smith B, Oellerich M, Panteghini M, Apple F, et al. The changing face of laboratory medicine: a more service and less academically oriented profession? Clin Chem 2015;61:322-9.
6. Adeli K. Value of the laboratory in clinical medicine. Presented at the Euromedlab 2013. Available at http://euromedlab.expomeeting. it/k-adeli. Accessed July 2015.
7. Blick KE. No more STAT testing. MLO Med Lab Obs 2005;37:22.
8. Plebani M, Panteghini M. Promoting clinical and laboratory interaction by harmonization. Clin Chim Acta 2014;432:15-21.
9. The NHS atlas of variation in diagnostic services. Available at www.rightcare.nhs.uk/index.php/atlas/diagnostics-the-nhsatlas-of-variation-in-diagnostics-services (Accessed July 2015).
10. National Collaborating Centre for Cancer (UK). National Institute for Health and Clinical Excellence (NICE): Guidance. Ovarian cancer: the recognition and initial management of ovarian cancer. Cardiff, UK: National Collaborating Centre for Cancer, 2011.
11. Dolci A, Scapellato L, Infusino I, Panteghini M. Results of the implementation of recommendations for appropriate use of tumor biomarkers (TBM) in a university hospital. Clin Chem Lab Med 2007;45:S343.
12. Ferraro S, Mozzi R, Panteghini M. Tumor marker ordering: do not lose control. A prospective clinical trial. Am J Clin Pathol 2015;144:649-58.
13. Plebani M. Charting the course of medical laboratories in a changing environment. Clin Chim Acta 2002;319:87-100.
14. Bruns DE, Boyd JC. Assessing the impact of biomarkers on patient outcome: an obligatory step. Scand J Clin Lab Investig 2010;70(Suppl 242):85-9.
15. Bissell MG. Introduction: what's in a laboratory outcome? In: Bissell MG, editor. Laboratory-related measures of patient outcomes: an introduction. Washington, DC: AACC Press, 2000:3-10.
16. Panteghini M. Implementation of standardization in clinical practice: not always an easy task. Clin Chem Lab Med 2012;50:1237-41.
17. Panteghini M. Traceability as a unique tool to improve standardization in laboratory medicine. Clin Biochem 2009;42:236-40.
18. Panteghini M, Ceriotti F. Obtaining reference intervals traceable to reference measurement systems: is it possible, who is responsible, what is the strategy? Clin Chem Lab Med 2012;50:813-7.
19. Gallaher MP, Mobley LR, Klee GG, Schryver P. The impact of calibration error in medical decision making. National Institute of Standards and Technology - Chemical Science and Technology Laboratory, May 2004.
20. Bossuyt X, Louche C, Wiik A. Standardisation in clinical laboratory medicine: an ethical reflection. Ann Rheum Dis 2008;67:1061-3.
21. McLawhon RW. Patient safety and clinical effectiveness as imperatives for achieving harmonization inside and outside the clinical laboratory. Clin Chem 2011;57:936-8.
22. Panteghini M. Traceability, reference systems and result comparability. Clin Biochem Rev 2007;28:97-104.
23. Schimmel H, Zegers I, Emons H. Standardization of protein biomarker measurements: is it feasible? Scand J Clin Lab Investig 2010;70(Suppl 242):27-33.
24. Kallner A. Measurement performance goals: how they can be estimated and a view to managing them. Scand J Clin Lab Investig 2010;70(Suppl 242):34-9.
25. Braga F, Panteghini M. Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies. Clin Chim Acta 2014;432:55-61.
26. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Official Journal of the European Communities 1998 (Dec 7);L331:1-7.
27. Panteghini M, Forest JC. Standardization in laboratory medicine: new challenges. Clin Chim Acta 2005;355:1-12.
28. Braga F, Infusino I, Panteghini M. Performance criteria for combined uncertainty budget in the implementation of metrological traceability. Clin Chem Lab Med 2015;53:905-12.
29. Panteghini M. Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement. Clin Chem Lab Med 2010;48:7-10.
30. Braga F, Infusino I, Panteghini M. Role and responsibilities of laboratory medicine specialists in the verification of metrological traceability of in vitro medical diagnostics. J Med Biochem 2015;34:282-7.
31. Infusino I, Schumann G, Ceriotti F, Panteghini M. Standardization in clinical enzymology: a challenge for the theory of metrological traceability. Clin Chem Lab Med 2010;48:301-7.
32. Braga F, Panteghini M. Standardization and analytical goals for glycated hemoglobin measurement. Clin Chem Lab Med 2013;51:1719-26.
33. Ceriotti F. The role of External Quality Assessment Schemes in monitoring and improving the standardization process. Clin Chim Acta 2014;432:77-81.
34. Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011;57:1670-80.
35. Thienpont LM, Van Uytfanghe K, Rodriguez Cabaleiro D. Metrological traceability of calibration in the estimation and use of common medical decision-making criteria. Clin Chem Lab Med 2004;42:842-50.
36. Petersen PH, Fraser CG, Kallner A, Kenny D. Strategies to set global analytical quality specifications in laboratory medicine. Scand J Clin Lab Investig 1999;59:475-585.
37. Panteghini M, Sandberg S. Defining analytical performance specifications 15 years after the Stockholm conference. Clin Chem Lab Med 2015;53:829-32.
38. Sandberg S, Fraser C, Horvath AR, Jansen R, Jones G, Oosterhuis W, et al. 1st EFLM strategic conference on 'Defining analytical performance goals 15 years after the Stockholm Conference on Quality Specifications in Laboratory Medicine'- Consensus agreement. Clin Chem Lab Med 2015;53:833-5.
39. Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med 2006;144:850-5.
40. Ferraro S, Braga F, Lanzoni M, Boracchi P, Biganzoli EM, Panteghini M. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review. J Clin Pathol 2013;66:273-81.
41. Panteghini M. Cardiac: is this biomarker ready for the prime time? Scand J Clin Lab Investig 2010;70:(Suppl 242):66-72.
42. Hallworth MJ, Epner PL, Ebert C, Fantz CR, Faye SA, Higgins TN, et al. on behalf of the IFCC Task Force on the Impact of Laboratory Medicine on Clinical Management and Outcomes. Current evidence and future perspectives on the effective practice of patient-centered laboratory medicine. Clin Chem 2015;61: 589-99.
43. Staub LP, Lord SJ, Simes RJ, Dyer S, Houssami N, Chen RY, et al. Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation. BMC Med Res Methodol 2012;12:12.
44. Lundberg GD. The need for an outcomes research agenda for clinical laboratory testing. J Am Med Assoc 1998;280:565-6.
45. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98.
46. Panteghini M. The new definition of myocardial infarction and the impact of troponin determination on clinical practice. Int J Cardiol 2006;106:298-306.
47. Sharkey SW. Commentary. Clin Chem 2012;58:43-4.
48. Owen A, Khan W, Griffiths KD. Troponin T: role in altering patient management and enabling earlier discharge from a district general hospital. Ann Clin Biochem 2001;38:135-9.
49. Zarich S, Bradley K, Seymour J, Ghali W, Traboulsi A, Mayall ID, et al. Impact of troponin T determinations on hospital resource utilization and costs in the evaluation of patients with suspected myocardial ischemia. Am J Cardiol 2001;88:732-6.
50. Collinson PO, Rao AC, Canepa-Anson R, Joseph S. Impact of European Society of Cardiology/American College of Cardiology guidelines on diagnostic classification of patients with suspected acute coronary syndromes. Ann Clin Biochem 2003;40:156-60.
51. Dominici R, Dolci A, Valente C, Infusino I, Panteghini M. One-year audit of the implementation of protocols for optimal use of cardiac biomarkers in an Italian university hospital. Clin Chem Lab Med 2007;45:S229.
52. Mills NL, Churchhouse AM, Lee KK, Anand A, Gamble D, Shah AS, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. J Am Med Assoc 2011:305:1210-6.
53. Thokala P, Goodacre SW, Collinson PO, Stevens JW, Mills NL, Newby DE, et al. Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction. Heart 2012;98:1498-503.
54. Hollander JE. Highly sensitive troponins. The answer or just more questions? J Am Coll Cardiol 2009;54:1173-5.
55. Jesse RL. On the relative value of an assay versus that of a test. A history of troponin for the diagnosis of myocardial infarction. J Am Coll Cardiol 2010;55:2025-8.
56. Omland T. Sensitive cardiac troponin assays: sense and sensibility. Eur Heart J 2012;33:944-6.
57. Daniels LB. The enemy of good? Making the most of highly sensitive troponin assays. J Am Coll Cardiol 2013;61:1914-6.
58. Wu AH, Bolger AF, Hollander JE. Growing pains with the use of high-sensitivity cardiac troponin assays. J Am Coll Cardiol 2013;62:1250-1.
59. Kramer CM. Avoiding the imminent plague of troponinitis. The need for reference limits for high-sensitivity cardiac troponin T. J Am Coll Cardiol 2014;63:1449-50.
60. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
61. de Lemos JA, Morrow DA, de Filippi CR. Highly sensitive troponin assays and the cardiology community: a love/hate relationship? Clin Chem 2011;57:826-9.
62. Ferraro S, Panteghini M. Laboratory medicine as the science that underpins medicine: the "high-sensitivity" troponin paradigm. Clin Chem Lab Med 2015;53:653-64.
63. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003;348:1104-11.
64. Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, et al. Soluble CD40L. Risk prediction after acute coronary syndromes. Circulation 2003;108:1049-52.
65. Halldórsdóttir AM, Stoker J, Porche-Sorbet R, Eby CS. Soluble CD40 ligand measurement inaccuracies attributable to specimen type, processing time, and ELISA method. Clin Chem 2005;51:1054-7.
66. Ivandic BT, Spanuth E, Haase D, Lestin HG, Katus HA. Increased plasma concentrations of soluble CD40 ligand in acute coronary syndrome depend on in vitro platelet activation. Clin Chem 2007;53:1231-4.
67. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, et al. Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-24.
68. Aakre KM, Langlois MR, Watine J, Barth JH, Baum H, Collinson P, et al. Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation. Clin Chem Lab Med 2013;51:1217-26.
69. Bingisser R, Cairns C, Christ M, Hausfater P, Lindahl B, Mair J, et al. Cardiac troponin: a critical review of the case for point-of-care testing in the ED. Am J Emerg Med 2012;30: 1639-49.
70. Epner PL, Gans JE, Graber ML. When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine. Br Med J Qual Saf 2013;22(Suppl 2):ii6-10.
71. Zhi M, Ding EL, Theisen-Toupal J, Whelan J, Arnaout R. The landscape of inappropriate laboratory testing: a 15-year metaanalysis. PLoS One 2013;8:e78962.
72. Büttner J. Good laboratory practice: the medical aspects. Eur J Clin Chem Clin Biochem 1997;35:251-6.
73. Ng VL. Utilization management in the core laboratory. Clin Chim Acta 2014;427:154-7.
74. Waldron JL, Ford C, Dobie D, Danks G, Humphrey R, Rolli A, et al. An automated minimum retest interval rejection rule reduces repeat CRP workload and expenditure, and influences clinicianrequesting behaviour. J Clin Pathol 2014;67:731-3.
75. Lang T. The Association for Clinical Biochemistry and Laboratory Medicine. National minimum re-testing interval project. Prepared for the Clinical Practice Group of the ACB and supported by the Royal College of Pathologists, 2013:1-36.
76. Hickner J, Thompson PJ, Wilkinson T, Epner P, Sheehan M, Pollock AM, et al. Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results. J Am Board Fam Med 2014;27:268-74.
77. Graziani MS, Secchiero S, Terreni A, Caldini A, Panteghini M. The laboratory role in chronic kidney disease (CKD) in Italy: need of harmonization. Biochim Clin 2015;39. In press.
78. Plebani M, Lippi G. Reference values and the journal: why the past is now present. Clin Chem Lab Med 2012;50:761-3.
79. International Organization for Standardization. ISO 15189:2012: Medical laboratories: particular requirements for quality and competence. Geneva, Switzerland: International Organization for Standardization, 2012.
80. Ceriotti F, Hinzmann R, Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009;46:8-17.
81. Fraser CG. Reference change values. Clin Chem Lab Med 2011;50:807-12.
82. Dolci A, Scapellato L, Mozzi R, Panteghini M. Imprecision of tumour biomarker measurements on Roche Modular E170 platform fulfills desirable goals derived from biological variation. Ann Clin Biochem 2010;47:171-3.
83. Dolci A, Scapellato L, Panteghini M. One-year audit of the implementation of recommendations for optimal use of tumor biomarkers in a university hospital. Biochim Clin 2008;32: 181-5.
84. Panteghini M, Cuccia C, Pagani F, Bonetti G. Gli "enzimi cardiaci" nell'era delle troponine: cosa salvare. Biochim Clin 1999;23:378-85.
85. Laposata ME, Laposata M, Van Cott EM, Buchner DS, Kashalo MS, Dighe AS. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med 2004;128:1424-7.
86. Lim EM, Sikaris KA, Gill J, Calleja J, Hickman PE, Beilby J, Vasikaran SD. Quality assessment of interpretative commenting in clinical chemistry. Clin Chem 2004;50:632-7.
87. Plebani M, Ceriotti F, Messeri G, Ottomano C, Pansini N, Bonini P. Laboratory network of excellence: enhancing patient safety and service effectiveness. Clin Chem Lab Med 2006;44:150-60.
88. Plebani M. Interpretative commenting: a tool for improving the laboratory-clinical interface. Clin Chim Acta 2009;404:46-51.
89. Campbell CA, Horvath AR. Harmonization of critical result management in laboratory medicine. Clin Chim Acta 2014;432: 135-47.
90. Piva E, Pelloso M, Penello L, Plebani M. Laboratory critical values: automated notification supports effective clinical decision making. Clin Biochem 2014;47:1163-8.
91. Panteghini M. The future of laboratory medicine: understanding the new pressures. Clin Biochem Rev 2004;25:207-15.